GUBRF Financials: Gubra A/S AI Analysis

Home

Stock

GUBRF

Financials

GUBRF Financial

Gubra A/S

0%

$0

As of today:Mar 25, 15:46:12 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is GUBRF?

Gubra A/S engages in providing research and development services to pharmaceutical and biotechnology companies on a contract basis. The Company’s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine learning (ML) and artificial intelligence (AI). The firm's business activity are divided into two segments: The CRO Segment offers specialized profitable pre-clinical contract research services at attractive margins within metabolic and fibrotic disease areas such as diabetes, obesity, chronic kidney disease; and The Discovery and Partnership Segment is based on an internal target and drug discovery engine for identification and design of peptide-based drug partnering candidates within metabolic and fibrotic diseases.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

GUBRF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	2,694	2,636	265	205	199	255
Revenue Growth (YoY)	917%	894.99%	28.99%	3%	-22%	48%
Cost of Revenue	80	80	101	90	101	89
Gross Profit	2,556	2,556	164	114	97	165
Selling, General & Admin	168	104	62	47	38	29
Research & Development	238	64	47	43	37	16
Operating Expenses	406	406	214	162	99	77
Other Non Operating Income (Expenses)	-4	0	5	5	8	0
Pretax Income	2,212	2,154	-42	-42	6	87
Income Tax Expense	463	463	-5	1	1	19
Net Income	1,748	1,690	-36	-44	4	67
Net Income Growth	-4,956%	-4,794%	-18%	-1,200%	-94%	458%
Shares Outstanding (Diluted)	16.34	16.28	16.3	15.17	16.34	16.34
Shares Change (YoY)	3%	0%	7%	-7%	0%	0%
EPS (Diluted)	106.91	103.82	-2.23	-2.93	0.26	4.15
EPS Growth	-4,748%	-4,738%	-24%	-1,213%	-94%	434.99%
Free Cash Flow	1,693	1,693	-27	-60	10	61
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	94.87%	96.96%	61.88%	55.6%	48.74%	64.7%
Operating Margin	81.92%	81.56%	-18.86%	-22.92%	-0.5%	34.5%
Profit Margin	64.88%	64.11%	-13.58%	-21.46%	2.01%	26.27%
Free Cash Flow Margin	62.84%	64.22%	-10.18%	-29.26%	5.02%	23.92%
EBITDA	--	2,167	-35	-38	5	98
EBITDA Margin	--	82.2%	-13.2%	-18.53%	2.51%	38.43%
D&A For EBITDA	--	17	15	9	6	10
EBIT	2,207	2,150	-50	-47	-1	88
EBIT Margin	81.92%	81.56%	-18.86%	-22.92%	-0.5%	34.5%
Effective Tax Rate	20.93%	21.49%	11.9%	-2.38%	16.66%	21.83%

Follow-Up Questions

What are Gubra A/S's key financial statements?



According to the latest financial statement (Form-10K), Gubra A/S has a total asset of $1,319, Net profit of $1,690

What are the key financial ratios for GUBRF?



Gubra A/S's Current ratio is 7.62, has a Net margin is 64.11, sales per share of $161.89.

How is Gubra A/S's revenue broken down by segment or geography?



Gubra A/S largest revenue segment is Pre-clinical Contract Research, at a revenue of 220,218,000 in the most earnings release.For geography, United States is the primary market for Gubra A/S, at a revenue of 101,000,000.

Is Gubra A/S profitable?



yes, according to the latest financial statements, Gubra A/S has a net profit of $1,690

Does Gubra A/S have any liabilities?



yes, Gubra A/S has liability of 173

How many outstanding shares for Gubra A/S?



Gubra A/S has a total outstanding shares of 16.33

Gubra A/S (GUBRF) Financial

GUBRF Stock Price Chart